Breast Lesion Localization Methods Market: By Technology, Radio Occult Lesion Localization, Others), Wire Guided localization, Magnetic Tracker, Others), By End-User, and Others) and Geography
Breast Lesion Localization Methods Market size was valued at US$ 467.91 million in 2023 and is poised to grow at a CAGR of 6.6% from 2024-2030. Breast cancer is characterized by the abnormal multiplication of the breast cells that will form lumps that may be nonmalignant or malignant in nature. Such abnormal breast cells usually form tumors that may often observe on X-ray. Breast cancer occurs commonly in women above 40 years of age and often it can be seen in men also. For the early detection of lumps or lesions, various methods are used. Breast lesion localization methods are used to detect the nonpalatable suspicious breast lesions during the biopsy.
Moreover, favorable reimbursement policies in developed countries coupled with the rising demand for better healthcare infrastructure globally are projected to bolster market growth over the forecast period. The advent of novel technologies in breast localization methods such as electromagnetic reflectors and magnetic trackers and prevalence of the breast cancer worldwide are driving the breast lesion localization methods market. In addition, an increase in awareness about the early detection of breast cancer due to the different awareness campaigns and initiatives taken by the respective government and nonprofit organizations such as the Canadian Breast Cancer Foundation, American Cancer Society, and World Health Organization (WHO) expected to boost the market growth further.
Study Period
2024-2030Base Year
2023CAGR
6.6%Largest Market
North-AmericaFastest Growing Market
Asia Pacific
Breast cancer is one of the most common diseases that affect women in both developed and developing countries. Breast cancer is the second-leading cause of cancer-related deaths in women worldwide, according to the American Cancer Society. Globally, the number of breast cancer cases has increased significantly. This can be attributed primarily to changing lifestyles, increased use of oral contraceptives, and an increase in the number of women undergoing cosmetic surgeries such as breast enhancement.
The risk of developing breast cancer rises with age. Aging increases the number of multipotent progenitors (a type of adult stem cell at the root of many breast cancers) while decreasing the number of myoepithelial cells, which line the milk-producing luminal cells of the breast and act as tumour suppressors. According to the American Cancer Society, one out of every eight invasive breast cancers develop in women under the age of 45. In contrast, approximately two out of every three invasive breast cancers occur in women aged 55 and up.
North America often leads in the adoption of advanced medical technologies. Breast lesion localization methods are likely to be well-established and widely used here, driven by a strong healthcare system, technological advancements, and high awareness.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 467.91 million |
|
Market CAGR |
6.6% |
|
By Technology |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global breast lesion localization methods market size was valued at US$ 467.91 million in 2023 and is projected to grow at a CAGR of 6.6% by 2030.
The breast lesion localization methods market key players are Cianna Medical, Inc. (U.S.) STERYLAB (Italy) Cook Group Inc. (U.S.) SOMATEX Medical Technologies GmbH (Germany) CP Medical, Inc. (Theragenics Corporation) (U.S.) R. Bard, Inc. (U.S.) Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) (U.S.) Faxitron, Inc. (Faxitron Bioptics, LLC) (U.S.) Endomagnetics Limited. (UK)
North America is the fastest-growing breast lesion localization methods market
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
